ロード中...
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study
INTRODUCTION: Dual antiplatelet therapy, aspirin and a P2Y(12) inhibitor, is recommended to prevent thrombotic complications of acute coronary syndrome. Clopidogrel plus acetylsalicylic acid combination is the most commonly used dual antiplatelet therapy recommended by international guidelines and i...
保存先:
| 出版年: | Adv Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7467447/ https://ncbi.nlm.nih.gov/pubmed/32418143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01369-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|